🔎 Trials Near Me

Inicio › Esteatosis hepática › Arkansas

Ensayos clínicos de Esteatosis hepática en Arkansas

8 estudios sobre Esteatosis hepática buscan participantes en Arkansas.

Ciudades en Arkansas

Texto oficial del estudio (inglés)

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

  • 89bio Clinical Study Site, Little Rock
  • 89bio Clinical Study Site, North Little Rock
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

  • 89bio Clinical Study Site, Little Rock
  • 89bio Clinical Study Site, North Little Rock
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06318169

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

  • GSK Investigational Site, Little Rock
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 30 sept 2026 · NCT07704892

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

  • GSK Investigational Site, Little Rock
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 30 sept 2026 · NCT07701993

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  • Arkansas Gastroenterology - North Little Rock, North Little Rock
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

  • Akero Clinical Study Site, Little Rock
  • Akero Clinical Study Site, North Little Rock
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 21 sept 2026 · NCT06528314

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

  • Arkansas Gastroenterology, P.A, Little Rock
  • ARcare Center for Clinical Research, Little Rock
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 9 sept 2026 · NCT07288138

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

  • GSK Investigational Site, Little Rock
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 jul 2026 · NCT07221227

De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.